Insider Selling: Ekf Diagnostics Holding PLC (LON:EKF) Insider Sells 400,000 Shares of Stock

Ekf Diagnostics Holding PLC (LON:EKF) insider Adam Reynolds sold 400,000 shares of Ekf Diagnostics stock in a transaction dated Friday, May 24th. The shares were sold at an average price of GBX 33 ($0.43), for a total value of £132,000 ($172,481.38).

LON EKF traded down GBX 1 ($0.01) during trading on Friday, hitting GBX 31.75 ($0.41). The company’s stock had a trading volume of 436,281 shares, compared to its average volume of 206,806. The company has a market cap of $144.18 million and a P/E ratio of 14.43. The company has a quick ratio of 1.30, a current ratio of 1.75 and a debt-to-equity ratio of 1.38. Ekf Diagnostics Holding PLC has a 52 week low of GBX 24 ($0.31) and a 52 week high of GBX 41.10 ($0.54).

COPYRIGHT VIOLATION WARNING: This story was originally posted by Sundance Herald and is owned by of Sundance Herald. If you are accessing this story on another site, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this story can be viewed at

About Ekf Diagnostics

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Africa, and internationally. It offers DiaSpect Tm, an hemoglobin analyzer; DiaSpect Hemoglobin T Low to determine low levels of hemoglobin in plasma and serum specimens, aqueous solutions, or stored or banked erythrocytes; Hemo Control, a point-of-care hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a centrifuge that provides a hematocrit reading for six blood samples.

Further Reading: What is Forex?

Receive News & Ratings for Ekf Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekf Diagnostics and related companies with's FREE daily email newsletter.

Leave a Reply